Abivax (ABVX) Profit After Tax (2023 - 2026)

Abivax's Profit After Tax history runs 4 years deep, the most recent figure standing at -$56.7 million for Q1 2026.

• In Q1 2026, Profit After Tax fell 203.01% year-over-year to -$56.7 million; the TTM figure through Mar 2026 stood at -$56.7 million (down 149.15% YoY), while the FY2025 annual figure was -$391.2 million, down 107.79% from the prior year.
• Profit After Tax was -$56.7 million for Q1 2026 at Abivax, up from -$687.1 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $179.3 million in Q3 2025 to a low of -$687.1 million in Q4 2025.
• Historically, Profit After Tax has averaged -$67.6 million across 4 years, with a median of -$141130.2 in 2024.
• Biggest YoY gain for Profit After Tax was 195.6% in 2025; the steepest drop was 1534.54% in 2025.
• A 4-year view of Profit After Tax shows it stood at -$159.0 million in 2023, then soared by 73.56% to -$42.0 million in 2024, then slumped by 1534.54% to -$687.1 million in 2025, then jumped by 91.74% to -$56.7 million in 2026.
• The last three Profit After Tax figures came in at -$56.7 million (Q1 2026), -$687.1 million (Q4 2025), and $179.3 million (Q3 2025), per Business Quant data.